Oral gavage at a dose of 20 mg/kg fucoidan for 28 days significantly suppressed tumor growth and angiogenesis, reduced hemoglobin content in tumor tissue, and decreased CD31 and CD105 mRNA expression [73]. This evidence concerns the gene PECAM1 and neoplasm.